“…The SOX‐2 protein in cancer cells is involved in several processes such as proliferation, growth, tumorigenicity, chemoresistance, and metastasis (Liu, Lin et al., ). The elevated expression of SOX‐2 in patients with OSCC is associated with invasion and metastasis, as well as reduced survival of these patients (Yoshihama et al., ). In addition, inactivation of SOX‐2 increases the sensitivity of cells to a combination of radiation therapy and cisplatin treatment (Chou, Hu, Yu, & Yu, ).…”